A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)

Clinical trial NCT04914897 · TERMINATED

Trial details

NCT number: NCT04914897
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pleural Mesothelioma Non-small Cell Lung Cancer

Start date: 2021-09-23
Primary completion: 2023-07-18
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.